Why is Nectar Lifesci. falling/rising?

As of 04-Jul, Nectar Lifescience Ltd's stock price is currently at 22.76, reflecting a decline of 0.73, or 3.11%. The stock has underperformed its sector by 3.62% today and has experienced a trend reversal after three consecutive days of gains. Although the stock is trading higher than its 5-day moving averages, it remains below its 20-day, 50-day, 100-day, and 200-day moving averages. Over the past week, the stock has shown a modest increase of 2.57%, but it has significantly underperformed over the longer term, with a year-to-date decline of 41.64% and a one-year return of -26.44%. The company has reported strong financial results, including a 40% growth in net profit and consistent positive results over the last six quarters; however, it faces challenges such as a high debt-to-EBITDA ratio and a significant percentage of promoter shares being pledged, which may contribute to investor concerns.
In the broader market context, the Sensex has experienced a slight decline of 0.74% over the past week, contrasting with Nectar Lifescience's recent performance. While the stock has shown some positive short-term movement, its long-term performance remains weak, particularly when compared to the benchmark indices, which have posted gains over the same periods. The company's ability to generate returns has been hampered by low profitability metrics and high debt levels, leading to a lack of investor confidence. Overall, the combination of strong short-term financial results and persistent long-term weaknesses is contributing to the stock's current downward movement.